News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Caraco Pharmaceutical Laboratories, Ltd. (CPD) Gets FDA Nod to Resume U.S. Operations


8/28/2012 7:45:31 AM

Indian generic drug maker Sun Pharmaceutical Industries Ltd. (524715.BY) said Tuesday the U.S. drug regulator has allowed resumption of operations at unit Caraco Pharmaceutical Laboratories Ltd.'s manufacturing facility and packaging sites in Detriot and Wixom, Michigan. Caraco had to halt operations at Detriot and Wixom after the U.S. Food and Drug Administration found some drug-manufacturing defects in 2009. The FDA has allowed production of Carvedilol USP and Paramomycin USP drugs from these facilities, India's largest drug maker by market capitalization said in a statement.

Read at Fox News
Read at EconomicTimes
Read at The Hindu Business Line
Read at Money Control
Read at PharmaBiz


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES